Back
On-Demand Webinar
Share

Walking a Fine Line: Safe and Effective Management of Type 2 Diabetes in Older Adults

Join us for this interactive live webinar that will explore diabetes management in older adults providing expert insight into the management of type 2 diabetes in older adults including individualization of treatment goals, use of fixed-ratio combination (FRC) insulin and GLP-1 RA, and management considerations in the long-term care facility setting.

Release : Dec 30, 2021 | Expires : Dec 30, 2022
Maximum Credits

Physicians : Maximum Of 0.25 AMA PRA Category 1 Credits

Registered Nurses : 0.25 Nursing Contact Hours

Course fee

$180.00

Purchase Activity

Target Audience

Nulla velit mauris, molestie quis massa eu, hendrerit pellentesque ipsum. Phasellus vitae posuere felis. Donec bibendum sed tortor ut cursus. Mauris accumsan massa vitae ultricies tempus. In et aliquam nulla, nec luctus nunc. Maecenas malesuada lacus in libero viverra, eu blandit magna scelerisque. Proin augue nunc, sodales vel nisi vel, ultricies faucibus felis. Nam massa dui, malesuada sit amet placerat non, lacinia varius dui.Nulla velit mauris, molestie quis massa eu, hendrerit pellentesque ipsum. Phasellus vitae posuere felis. Donec bibendum sed tortor ut cursus. Mauris accumsan massa vitae ultricies tempus. In et aliquam nulla, nec luctus nunc. Maecenas malesuada lacus in libero viverra, eu blandit magna scelerisque. Proin augue nunc, sodales vel nisi vel, ultricies faucibus felis. Nam massa dui, malesuada sit amet placerat non, lacinia varius dui.

Learning Objectives

  • The target audience for this activity includes pharmacists, including clinical and health-system, ambulatory care, and community pharmacists, who care for patients living with HIV or at risk for HIV. In addition, the target audience includes pharmacy directors, chief pharmacy officers, and other stakeholders in health-system pharmacy. At the completion of this activity, the participant will be able to:
  • Describe guideline-recommended ART regimens and appropriate counseling points for treatment-naïve patients, heavily treatment–experienced patients, and switch strategies for virologically suppressed patients living with HIV.
  • Given patient cases, integrate individual patient factors such as drug–drug interactions, comorbidities, adverse events, pregnancy status, adherence, and dosing preferences when selecting optimal ART.

Faculty

Ursula Matulonis, MD

Program Director

Robert L. Coleman, MD, FACOG,

FACS

Ursula Matulonis, MD

Program Director

Robert L. Coleman, MD, FACOG,

FACS

Ursula Matulonis, MD

Program Director

Robert L. Coleman, MD, FACOG,

FACS

Accreditation

This activity is jointly provided by ProCE, LLC and SIDP. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-280-H02-P has been assigned to this home study, knowledge-based activity. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Disclosure

It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Melissa Badowski has disclosed that she has no conflicts of interest to report. Anne Daniels has disclosed that she has received consulting fees from Theratechnologies. Jason Schafer has disclosed that he has received consulting fees from Merck, Theratechnologies, and ViiV.

Funding

This activity is supported by educational grants from Merck Sharp & Dohme Corp. and ViiV Healthcare.

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.